KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GoodRx Holdings (GDRX) Tax Provisions (2019 - 2025)

GoodRx Holdings' Tax Provisions history spans 7 years, with the latest figure at $8.8 million for Q4 2025.

  • For Q4 2025, Tax Provisions rose 87.79% year-over-year to $8.8 million; the TTM value through Dec 2025 reached $26.1 million, up 73.19%, while the annual FY2025 figure was $26.1 million, 73.19% up from the prior year.
  • Tax Provisions for Q4 2025 was $8.8 million at GoodRx Holdings, up from $5.0 million in the prior quarter.
  • Across five years, Tax Provisions topped out at $45.8 million in Q4 2021 and bottomed at -$46.7 million in Q2 2023.
  • The 5-year median for Tax Provisions is $4.4 million (2024), against an average of $956950.0.
  • The largest YoY upside for Tax Provisions was 722.07% in 2021 against a maximum downside of 586.95% in 2021.
  • A 5-year view of Tax Provisions shows it stood at $45.8 million in 2021, then crashed by 106.06% to -$2.8 million in 2022, then skyrocketed by 144.5% to $1.2 million in 2023, then surged by 278.36% to $4.7 million in 2024, then skyrocketed by 87.79% to $8.8 million in 2025.
  • Per Business Quant, the three most recent readings for GDRX's Tax Provisions are $8.8 million (Q4 2025), $5.0 million (Q3 2025), and $6.7 million (Q2 2025).